TGFβ3 (G-9) Antibody sc-166833 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemTGFβ3 (G-9) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-166833
Antibody TypePrimary Antibodies
NCBI Gene AliasesTGF-beta3, RNHF, LDS5, ARVD, ARVD1, TGF-beta-3, Tgfb-3
Quantity200 µg/ml
CloneG-9
ClonalityMonoclonal
FormatPurified
Hostmouse
Conjugate/TagUnconjugated
Reactivitymouse, rat, human
ApplicationsWB, IP, IF, IHC(P), ELISA
NCBI Full Gene Nametransforming growth factor, beta 3, transforming growth factor beta 3
TargetTGFbeta3
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Evaluation of the therapeutic efficacy of human bone marrow mesenchymal stem cells with COX-2 silence and TGF-β3 overexpression in rabbits with antigen-induced arthritisExperimental cell researchJanuary 1, 2022He T, Sun S.

(2) Expression of Transforming Growth Factor Beta Isoforms in Canine Endometrium with Cystic Endometrial Hyperplasia-Pyometra ComplexAnimals : an open access journal from MDPIJune 21, 2021Rybska M, Woźna-Wysocka M, Wąsowska B, Skrzypski M, Kubiak M, Błaszak B, Łukomska A, Nowak T, Jaśkowski JM.anti-TGFβ2 (1:250 dilution, sc-90, Santa Cruz Biotechnology, Dallas, TA, USA) and anti-TGFβ3 (1:250 dilution, sc-166833, Santa Cruz Biotechnology, Dallas, TA, USA) in TBST supplemented with 1% BSA at 4 ◦ C. Membranes were

(3) The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine VaricoceleNutrientsFebruary 25, 2021Antonuccio P, Marini HR, Micali A, Romeo C, Granese R, Retto A, Martino A, Benvenga S, Cuzzocrea S, Impellizzeri D, et al.anti-transforming growth factor-beta3 (TGF-β3), (1:1000, Santa Cruz Biotechnology, Heidelberg, Germany, sc-166833), anti-claudin-11 (1:100, Santa Cruz Bio-technology, Heidelberg, Germany, sc-271232), or anti-occludin

(4) Circulating extracellular vesicle-associated TGFβ3 modulates response to cytotoxic therapy in head and neck squamous cell carcinomaCarcinogenesisDecember 31, 2019Rodrigues-Junior DM, Tan SS, Lim SK, Leong HS, Melendez ME, Ramos CRN, Viana LS, Tan DSW, Carvalho AL, Iyer NG, et al.

(5) TGF-β2-induced ANGPTL4 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of boneOncotargetAugust 15, 2017Li B, Qian M, Cao H, Jia Q, Wu Z, Yang X, Ma T, Wei H, Chen T, Xiao J.

(6) Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMTPloS oneJanuary 1, 2014Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M.

(7) Effect of CLC-2 on the cytoskeleton in human trabecular meshwork cellsMolecular medicine reportsOctober 1, 2013Wang HW, Zheng YJ.(SC‑81871), anti‑actin (SC‑81760), anti‑vinculin (SC‑55465), anti‑β‑catenin (SC‑7963), β ‑actin (SC‑130301), TGF‑ β (SC‑166833) and Smad2 (SC‑101153). All antibodies were acquired from Santa Cruz Biotechnology, Inc. (Santa Cruz,

Be the First to Write a Review!

TGFβ3 (G-9) Antibody

TGFβ3 (G-9) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (7)

Reviews

TGFβ3 (G-9) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map